ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
| Project Title | Institution / Principal Investigator(s) |
Grant Type |
Year | State |
|---|---|---|---|---|
| Development of a Screening Module to Assess Sibling-Related Psychosocial Risk in Families of Children with Cancer | Boston University / Kristin Long, PhD | Psychosocial Grants | 2014 | Massachusetts |
| Web-Based Cognitive-Behavioral Treatment for Insomnia in Adolescent Cancer Survivors | Dana-Farber Cancer Institute / Eric Zhou, PhD | Psychosocial Grants | 2016 | Massachusetts |
| Phase I Trial of Indoximod in Combination with Temozolomide-based Therapy for Children with Progressive Primary Brain Tumors | Georgia Health Sciences University Research Institute, Inc. / Theodore Johnson, M.D., Ph.D. | Bio-Therapeutic Impact Award | 2014 | Georgia |
| HA-1 TCR T-cell Immunotherapy for Acute Leukemia | Fred Hutchinson Cancer Research Center / Marie Bleakley, M.D., Ph.D. | Bio-Therapeutic Impact Award | 2014 | Washington |
| Next-Generation Personalized Neuroblastoma Therapy (Nepenthe) | Children’s Hospital of Philadelphia / Yael Mosse, MD & John Maris, MD | Bio-Therapeutic Impact Award | 2015 | Pennsylvania |
| Immunotherapy of Neuroblastoma with CAR.GD2 NKT Cells | Baylor College of Medicine / Leonid S. Metelitsa, M.D., Ph.D. | Bio-Therapeutic Impact Award | 2014 | Texas |
| Natural Killer T cells with an IL-15-armored GD2-specific CAR for Children with Neuroblastoma | Baylor College of Medicine / Andras Heczey, MD | Bio-Therapeutic Impact Award | 2017 | Texas |
| Molecular Annotation for Treatment of Childhood Cancers Trial: Neuroblastoma (MATCH-NB) | Children’s Hospital of Philadelphia / Yael Mosse, M.D. | Bio-Therapeutic Impact Award | 2015 | Pennsylvania |
| Targeting Chondroitin Sulphate Proteoglycan 4 (CSPG4) in Glioblastoma | University of North Carolina / Gianpietro Dotti, MD & Barbara Savoldo, MD/PhD | Reach Grants | 2017 | North Carolina |
| Targeted Inhibition of the DNA Damage Response Pathway: A Novel Intervention in the Treatment of Pediatric Leukemias | National Cancer Institute / Andre Nussenzweig, Ph.D. | Reach Grants | 2014 | Maryland |